Parallel in-register contact propensity predicts the Amyloidogenicity of ADan and ABri in familial dementias

平行登记接触倾向预测家族性痴呆症中 ADan 和 ABri 的淀粉样蛋白原性

阅读:2

Abstract

Familial Danish dementia (FDD) and British dementia (FBD) are rare neurodegenerative diseases caused by stop-codon mutations in the Bri2 gene, leading to amyloid deposits formed by the aggregation of mutant ADan and ABri peptides, respectively. FDD symptoms usually manifest decades earlier than those of FBD. Probably due to the rarity of these conditions, the aggregation mechanisms of ADan and ABri and the molecular basis for FDD's earlier onset remain underexplored. Here, we computationally investigated the conformational dynamics of monomeric wild-type Bri23 and the two mutants ADan and ABri, as well as their self-assembly dynamics from dimers to hexamers using atomistic discrete molecular dynamics simulations. Our results aligned with earlier experimental work on the monomeric structures. We also confirmed that Bri23 is less amyloidogenic, showing significantly lower self-assembly propensity compared to ADan and ABri, which both favored forming β-sheet-rich oligomers. In amyloid aggregation, the critical nucleation event involves the transition from unaligned or misaligned oligomers to well-aligned fibril seeds featuring parallel in-register (PAIR) intermolecular β-sheets - the structural hallmark of mature fibrils. Notably, ADan showed a higher propensity than ABri to form longer PAIR intermolecular β-sheets within oligomers, suggesting a lower fibril nucleation barrier (i.e., higher amyloidogenicity) and thereby explaining FDD's earlier onset. We further identified nucleation "hotspots" with high PAIR propensities in both ADan and ABri, which may serve as potential therapeutic targets. Together, these insights into the early aggregation dynamics of these rare dementias enhance our understanding of the aggregation-nucleation process and disease mechanisms.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。